Skip to main content

Companies researching Opdivo (nivolumab)

Opdivo, known generically as nivolumab, is an immunotherapy medication employed to treat multiple forms of cancer.

List of companies that research Opdivo (nivolumab)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies

United States

Pharmaceutical Manufacturing

39k

$46B

Opdivo (nivolumab)

United States

Business Consulting and Services

1.3k

Opdivo (nivolumab)

United States

Hospitals and Health Care

1.5k

Opdivo (nivolumab)

United States

Pharmaceutical Manufacturing

3.6k

$15M

Opdivo (nivolumab)

United States

Business Consulting and Services

97

$18M

Opdivo (nivolumab)

United States

Hospitals and Health Care

21k

$5.5B

Opdivo (nivolumab)

United States

Real Estate

1k

$3.1M

Opdivo (nivolumab)

United States

Non-profit Organizations

96

Opdivo (nivolumab)

United States

Medical Practices

201

$36M

Opdivo (nivolumab)

India

Pharmaceutical Manufacturing

33k

Opdivo (nivolumab)

Showing top companies out of 28 that research Opdivo (nivolumab). Get the full list on TheirStack.

Frequently asked questions